The Form 4 filing, a report of an insider's stock trades to the SEC, was filed on November 18, 2026. The sale took place on November 16, 2026. Neill Reynolds serves as senior vice president and chief financial officer of Ralliant Corp (RAL).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 42,086 |
| Price | $67.12 |
| Total Transaction Value | $2,824,812.32 |
| Insider | |
| Ticker Symbol | RAL |
| Company | Ralliant Corp |
| Insider Name | Reynolds Neill |
| Insider Title | SVP - Chief Financial Officer |
| Sector - Industry | Technology - Electronic Components |
| Holdings | |
| Total Shares Owned After Transaction | 46,524 |
| Position Size Change | 47.50% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a stock sale, recorded with transaction code S. The filing information lists one sale transaction by one insider.
What was the average price of the transaction?
The reported average sale price was $67.12 per share.
How did this transaction affect the insider's holdings?
He sold 42,086 shares and reported 46,524 shares owned afterward. Those figures put his reported holdings before the sale at 88,610 shares. The sale covered 47.50% of that earlier balance.
What's the total transaction value?
The total reported sale value was $2,824,812.32. That amount covers the single transaction reported here.
Are there any special circumstances around this transaction?
The transaction details include a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. No filing footnote text or plan terms are available here. It is therefore unclear whether the reference covers this specific sale or the filing more broadly. No plan start date or trading schedule is available, and the reference alone does not confirm that the sale followed a plan.
For research purposes only; not investment advice.